Human cathepsin F (GenBank Accession No. NM_003793), CD33 signal peptide(a.a. 1-16) + cathepsin F (a.a. 20-end), with C-terminal His-tag, MW = 53 kDa (more than 58kDa after post-modification), expressed in FreeStyle 293-F cells.
Specific activity: >= 0.9 pmole/min/ug.
Immunogen Region
CD33 1-16, CathepsinF 20-end
Tag
C-terminal His-tag
Formulation
45 mM Na Acetate pH 5.5, 135 mM NaCl and 10% glycerol
Species
Human
Application
Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling
Notes
Enzyme activity wasmeasured in a buffer containing 100 mMSodium acetate (pH 5.5), 2 mM EDTA, 8 mMDTT, 0.05% Brij, and 20 uM substrate (Z-FRAMC),with 3.75-30 ng/ul Cathepsin F.Reaction was done at 30°C for 40-120min, and fluorescence signal was measuredat Ex360 nm/Em460 nm. Enzyme waspreactivated in 50 mM sodium acetate pH4.5, 5 mM DTT buffer for 90 min at RT prior toreaction.
Avoid freeze/thaw cycles.
GenBank
NM_003793
Mw(kda)
53 kDa
Synonyms
CTSF, CATSF
Uniprot
Q9UBX1
Shipping Temperature
-80°C (dry ice)
Format
Aqueous buffer solution
Storage
At least 6 months at -80°C.
Reference
1. Kaakinen R. et al., Atherosclerosis 192 (2), 323-327 (2007). 2. Vazquez-Ortiz G. et al., BMC Cancer 5, 68 (2005).Application Reference(s):1. Orbe, J., et al. J Med Chem . 2015 Apr 9;58(7):2941-57. doi: 10.1021/jm501939z. Discovery and safety profiling of a potent preclinical candidate, (4-(4-(((3R)-3-(hydroxycarbamoyl)-8-azaspiro(4.5)decan-3-yl)sulfonyl)phenoxy)-N-methylbenzamide) (CM-352), for the prevention and treatment of hemorrhage (2015)